Clinical and Scientific Experts Available from The ALS Association to Discuss Newly Released Research on Gulf War Veterans and Increased Risk of Lou Gehrig's Disease


REMINDER, Sept. 22, 2003 (PRIMEZONE) --


 WHAT:      Two studies on 1991 Gulf War veterans and amyotrophic
            lateral sclerosis, commonly known as Lou Gehrig's disease
            will be published Sept. 22 in Neurology, the scientific
            journal of the American Academy of Neurology.  The
            research finds that the Gulf War veterans have developed
            ALS at approximately twice the rate of the general
            population.  The ALS Association played an instrumental
            role in consulting with the government in the decision to
            conduct the research.

 WHO:       Michael Havlicek, President & CEO, The ALS Association
            Mary Lyon, Vice President, Patient Services, The ALS
            Association
            Dr. Lucie Bruijn, Science Director and Vice President,
            The ALS Association
            Steve Gibson, Vice President, Government Relations &
            Public Affairs, The ALS Association

 CONTACT:   Jeff Snyder
            Vice President, Communications
            The ALS Association 
            (818) 587-2220

                             BACKGROUND

The ALS Association is the only national not-for-profit voluntary health organization devoted solely to the fight against ALS. Commonly known as Lou Gehrig's disease, amyotrophic lateral sclerosis is a progressive neurodegenerative disease that affects as many as 30,000 Americans at any given time. ALS kills brain and spinal cord cells that control muscle movement, resulting in paralysis. The average life span of people with ALS is two to five years from time of diagnosis.

The A.L.S. Association logo is available at: http://media.primezone.com/prs/single/?pkgid=525



            

Coordonnées